作为向STING-依赖性炎症的抑制剂的醇衍生物的开发
Peng Zhou1, Gen Yang1, Yan Wang1
1Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, PR China.
研究人员开发了针对干扰素基因刺激器 (STING) 途径的新型醇衍生物. 化合物4dc在小鼠中显示出强大的STING抑制和减少损伤,提供了一种新的抗炎治疗策略.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 干扰素基因刺激器 (STING) 途径的不断激活有助于炎症和自身免疫性疾病.
- 刺痛抗剂是这些疾病的有前途的治疗药物.
研究的目的:
- 设计,合成和评估作为STING抑制剂的新型醇衍生物.
- 为了确定具有潜在抗炎性质的强大的STING抗剂.
主要方法:
- 灵感来源于已知STING抑制剂 (H151,C178) 的醇衍生物的结构设计.
- 通过基于细胞的测试 (RAW-LuciaTM ISG,THP1-DualTM) 合成和体外评估STING抑制活性.
- 治疗疗效的体内评估在西斯胺诱导的急性损伤小鼠模型中.
主要成果:
- 几种合成的醇衍生物显示出有效的STING抑制活性.
- 与H151相比,4dc化合物表现出更高的功效,在各自细胞系中IC50值为0.14μM和0.39μM.
- 化合物4dc在小鼠模型中显著减轻了损伤症状.
结论:
- 化合物4dc代表了一种新的STING抑制剂的化学型.
- 这种新的化学实体显示出作为治疗STING介导疾病的抗炎剂的巨大潜力.
更多相关视频
07:30A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones
Published on: January 21, 2020
07:13Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
